Quantcast

Latest Hydromorphone Stories

2014-04-03 00:22:16

SAN DIEGO, April 2, 2014 /PRNewswire/ -- We are extremely disappointed that the U.S. Drug Enforcement Administration (DEA) Administrator, as she did in a Congressional hearing today, would repeat misinformation about Zohydro(TM) ER that has been demonstrated to be false. As informed health care experts and the U.S. Food and Drug Administration have noted for the record, Zohydro ER is no more potent than any other hydrocodone medication available. The facts are clear: Zohydro ER is the same...

2014-03-28 00:23:11

SAN DIEGO, March 27, 2014 /PRNewswire/ -- We agree with Governor Deval Patrick's intention to curb the epidemic of drug abuse in Massachusetts. However, we are extremely concerned by his unprecedented action with respect to a specific FDA-approved prescription medication. We believe Governor Patrick's ban on Zohydro(TM) ER only serves to unfairly restrict patient access to the only hydrocodone pain reliever available for long-term, daily, severe chronic pain patients who are obtaining relief...

Opioids Prescriptions Increase Significantly In Emergency Rooms
2014-03-17 05:06:33

April Flowers for redOrbit.com - Your Universe Online A new study from George Washington University (GW) reports dramatic increases in opioid analgesic prescriptions, such as Percocet, Vicodin, oxycodone and Dilaudid, during emergency room visits in the US from 2001 to 2010. These findings, reported in the journal Academic Emergency Medicine, were not explained by higher visit rates for painful conditions. The visit rates only rose moderately during the study period. “This trend is...

2014-03-04 08:32:42

Composition of Matter Patents Issued in Multiple Countries for KemPharm's Lead Abuse-Deterrent Hydrocodone Prodrug CORALVILLE, Iowa, March 4, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that multiple global composition of matter patents have been issued for KP201 in Russia, Ukraine, Kazakhstan, Japan, Australia, New Zealand and South Africa....

2014-02-26 08:29:29

CORALVILLE, Iowa, Feb. 26, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that President and CEO, Travis Mickle, Ph.D., will present at the Cowen and Company 34(th) Annual Health Care Conference at the Boston Marriott Copley Place in Boston, MA. Among the topics to be discussed, Dr. Mickle will provide an overview of KemPharm's development pipeline,...

2014-02-05 08:29:57

CORALVILLE, Iowa, Feb. 5, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that president and CEO, Travis Mickle, Ph.D., will present at the 16(th) Annual BIO CEO & Investor Conference. Hosted by the Biotechnology Industry Organization (BIO), the 16(th) Annual BIO CEO & Investor Conference will take place February 10-11 at the Waldorf Astoria in New...

2014-01-27 23:24:25

Family of Dennis McGuire Seeks Injunction Barring the Execution Protocol Used by the State of Ohio to Carry Out Dennis McGuire’s Death Sentence Columbus, OH (PRWEB) January 27, 2014 Richard W. Schulte, a partner with the Ohio law firm of Wright & Schulte LLC, together with his co-counsel, is representing the family of an Ohio death row inmate who allegedly suffered cruel and unusual punishment in a prolonged Ohio execution carried out by the state on January 16, 2014. According to...

2014-01-09 12:26:30

CORALVILLE, Iowa, Jan. 9, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that president and CEO, Travis Mickle, Ph.D. will present at the Biotech Showcase(TM) 2014 Conference being held in San Francisco January 13-15, 2014. Among the topics to be discussed, Dr. Mickle will provide an overview of KemPharm's development pipeline, including KP201, the...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related